Cullinan Therapeutics, Inc. CGEM
11.12 USD -0.61 (-5.20%)
Nov 10, 2026, 1:43 PM EST
10.95 Day range 12.04
7.25 52-week range 23.19
- YTD
- +7.44%
- 1 year
- +49.46%
CGEM revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | 0 | Not meaningful |
| FY 2024 | 2024-12-31 | 0 | 0 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | -18,943,000 | -100.00% |
| FY 2021 | 2021-12-31 | 18,943,000 | 18,943,000 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:12.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.